Notably, miR-155, which is often dysregulated in colorectal carcinoma (CRC), inhibits the transcription factor CEBPB, leading to the downregulation of miR-143 and the subsequent upregulation of its target genes, B7-H3 and B7-H4, in cancer cells [73]. The gene discussed is CD276; the disease is cancer.